Abstract S4-1: FinXX Final 5-Year Analysis: Results of the Randomised, Open-Label, Phase III Trial in Medium-to-High Risk Early Breast Cancer
暂无分享,去创建一个
A. Jukkola-Vuorinen | H. Joensuu | P. Kellokumpu-Lehtinen | M. Tanner | H. Lindman | R. Kokko | P. Bono | P. Auvinen | R. Huovinen | J. Ahlgren